Teva Pharmaceutical Industries Ltd. (TEVA) reported earnings of 89 cents in the third quarter of 2009, up 16% from the year-ago period and a cent above the Zacks Consensus Estimate. Strong sales of Copaxone and in the respiratory business helped drive earnings in the reported quarter. Net sales increased 25% to $3.55 billion, with the Barr acquisition contributing to sales across different geographical segments. The strengthening U.S. dollar adversely impacted net sales by $160 million or 6%. Revenue performance across key business segments was mixed. While the Pharmaceuticals Sales segment posted growth of 27% with revenues coming in at $3.4 billion, the active pharmaceutical ingredients (API) segment reported an 8% decline in growth with sales coming in at $136 million. Pharmaceutical segment sales were driven by strong performances in the North American, European and International segments. The launch of generic versions of Ortho Tri-Cyclen Lo ...

Dr Stock Pick HOT News & Alerts!

_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!

My Picks for Thursday October 29, 2009, are:

**************************************************************

AKAM, Akamai Technologies Inc.

AKAM provides market-leading managed services for powering video, dynamic transactions, and enterprise applications online.

AKAM’s Revenue for the third quarter 2009 was $206.5 million, a 5 percent increase over third quarter 2008 revenue of $197.3 million, and a 1 percent increase from second quarter 2009 revenue of $204.6 million.

More about AKAM at www.akamai.com

**************************************************************

CPE, Callon Petroleum Co.

CPE is engaged in the acquisition, development, exploration and operation of oil and gas properties primarily in the Gulf Coast region. CPE’s properties and operations are geographically concentrated in Louisiana,

...

We are initiating coverage of Oxygen Biotherapeutics, Inc. (OXBO) with an ‘Outperform’ rating. Despite what has been a tumultuous past for the company and a abysmal fate for competitors attempting to develop similar products, the potential upside that Oxycyte offers is too significant to ignore.  Does Oxycyte do what management says it does? (Key Efficacy Question) In theory, Oxycyte has the potential to be a wonder drug -- a sort of WD-40 of medicine. Preclinical data suggests that Oxycyte has astounding potential for the treatment of traumatic brain injury (TBI), decompression sickness, carbon monoxide poisoning, sickle cell crisis, organ preservation and as a neuroprotectant in patients with myocardial infarction or stroke. The effects in TBI were clearly evident in the phase I program conducted by Oxygen Bio in 2006. Initial phase II data from STOP-TBI will become available in 2010. However, data from small ...

EcoloCap Solutions Inc. will be hosting representatives from four continents in Korea this November in the first ever public unveiling of the company’s M-Fuel product, an innovative suspension fuel for use in diesel engines. M-Fuel, developed and manufactured by MBT (Micro Bubble Technologies), a subsidiary of EcoloCap Solutions Inc., is an innovative suspension fuel that far exceeds efficiencies for all conventional fuels. This environmentally-friendly and economical product is designed to offer fully scalable and customizable fuel solutions that increase efficiency, lower operating costs, and reduce emissions.

M-Fuel is a suspension mixture of 60% heavy oil, and 40% separated hydrogen and oxygen, plus a stabilizing additive. Nano Processing Units (NPUs) produce the fuel and can be configured to be integrated with an engine, producing fuel on demand, or the fuel can be pre-manufactured for delivery.

The event in Korea, scheduled for November 18th, will have representatives from more than

...

Ampal-American Israel Corp. is a holding company focused on acquired interests in energy and related businesses in the State of Israel or those businesses deemed Israel-related. The company has a 12.5 percent interest in East Mediterranean Gas Co. (EMC), which yesterday informed Ampal that it has secured three 18-year Gas Sale Agreements valued at $1.3 billion.

These announced agreements are in addition to three previous gas sale agreements between EMG and the Israeli Electric Company, Dorad Energy Ltd., and Nesher.

“The signing of the three agreements by EMG, as well as EMG’s active and ongoing negotiations with other potential customers, including electricity producers and industrial companies, buttresses our view that EMG’s gas supply is stable and reliable and, we believe, demonstrates that the energy market in Israel, as well as the financing sources for these projects, believe in the reliability and competitiveness of EMG’s gas,” Yosef A. Maiman, chairman, president and

...

The Nevada Company Ormat Technologies announced that Ormat Subsidiaries Ltd., its Israeli subsidiary, entered into a Joint Venture Agreement (JVA) with Sunday Energy Ltd. Sunday is a private Israeli energy company and the agreement will be to construct and operate solar-photovoltaic energy systems with a total capacity of 36 MW throughout Israel.

According to the JVA, Ormat will now own 70% of each special purpose entity (SPE) with Sunday contributing the rights to all of its property and roofs required to develop solar energy systems above 1 MW to SPE’s.

The agreement between Ormat and Sunday will have major effects throughout the industry. Sunday is a leading developer in the Israeli PV market while Ormat has over four decades of experience in the development, construction, financing and operation of hundreds of megawatts of renewable energy projects worldwide.

The estimated capital expenditure for 36 MW of solar power systems is

...

Syneron Medical Ltd. (ELOS) is set to acquire Primaeva Medical, Inc., an aesthetic technology firm based in Pleasanton, CA. The acquisition is expected to close before the end of 2009. Per the agreement, Syneron will acquire Primaeva for $7 million in cash and up to $23 million of additional payment based on the achievement of certain milestones. The Primaeva acquisition helps Syneron gain access to a new technology for the treatment of wrinkles. The Primaeva product uses the bipolar fractional radiofrequency (RF) energy for the treatment of skin wrinkles and laxity in a selective and predictable manner. Its unique energy delivery mechanism resulted in skin tightening with minimal downtime.   An important consideration in skin treatment is the excessive heating of skin. The Primaeva product eliminates this as the treatment temperature is preselected and energy is delivered directly within the dermis, thereby eliminating the uncertainty associated with ...

Pratt & Whitney Rocketdyne has been awarded a 10-month contract by Lockheed Martin for preliminary design of the high speed accelerator for a turbine-based combined-cycle (TBCC) propulsion system, which could support flight up to Mach 6. Pratt & Whitney Rocketdyne is a unit of United Technologies Corporation (UTX).  In Phase I of the TBCC Mode Transition Demonstrator Program, Pratt & Whitney Rocketdyne will develop preliminary designs for a dual-mode ramjet combustor with related control and fuel system components.  El Al , Israel 's national airline, signed a five-year, $70 million extension agreement with jet engine maker Pratt & Whitney for engine maintenance and overhaul. The service is for PW4060 engines on El Al's Boeing 767s and 747-400s. The agreement includes management and overhaul of the engines with an option to extend the contract for up to five more years.  United Technologies Corp.'s Sikorsky Aircraft received ...

Texas-based Noble Energy (NBL) is an independent oil and gas exploration and production (E&P) company with high-grade hydrocarbon assets across the U.S. and several international locations. Noble's U.S. onshore assets provide stable performance, while the offshore assets in the deepwater Gulf of Mexico offer significant growth opportunities over the medium to long-terms. The international operations of the company – with core positions in Equatorial Guinea and Israel – are a source of a low-cost, long-term production base; they do not require huge maintenance capital and diversify the overall portfolio.

Noble has a strong balance sheet with sufficient liquidity and financial flexibility. Management maintains a disciplined investment approach. They have been sensibly allocating resources to long-term development projects, which are vital for its future growth and to living within generated cash flows.

Going forward, the ongoing major development projects in deepwater Gulf of Mexico, Equatorial Guinea and Israel will create substantial

...

Oil traded around $66 a barrel on Monday, steadying after an earlier decline which extended last week’s 8.4 percent slide, as the U.S. dollar lost ground and stock markets moved higher.

The dollar gave up most of its earlier gain against a basket of currencies, boosting the appeal of oil and commodities to investors. European stocks firmed and U.S. equity futures pointed to a higher opening.

“It’s making some progress back up, largely due to the dollar,” said Rob Montefusco of Sucden Financial. “At the same time, we haven’t seen demand pick up and we need that to draw strength back into this sector at the moment.”

U.S crude was up 8 cents to $66.10 a barrel by 1308 GMT, after earlier falling as far as $65.41. London Brentwas down 11 cents to $65.00.

Iran test-fired a type of missile on Monday which defence analysts have said could hit Israel and U.S. bases in the

...